Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Enanta Pharmaceuticals, Inc.    ENTA

ENANTA PHARMACEUTICALS, INC.

(ENTA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ENANTA PHARMACEUTICALS, INC.
02/10/21 Q1 2021 Earnings Release (Projected)
03/02/21 Annual General Meeting
05/10/21 Interim 2021 Earnings Release (Projected)
08/10/21 Q3 2021 Earnings Release (Projected)
Past events on ENANTA PHARMACEUTICALS, INC.
01/12/21 | 08:20am JP Morgan Healthcare Conference
12/02/20 Piper Sandler Health Care Conference
12/01/20 | 09:15am Evercore ISI HealthCONx Conference
11/23/20 | 04:30pm FY 2020 Earnings Call
Upcoming sector events for ENANTA PHARMACEUTICALS, INC.
01/27/21 GALAPAGOS NV : Degroof Petercam Healthcare Conference
01/27/21 LONZA GROUP LTD : FY 2020 Earnings Release
01/27/21 | 08:30am LONZA GROUP LTD : FY 2020 Earnings Call
01/31/21 TURNING POINT THERAPEUTICS, INC. : Lung Cancer World Conference
More events
Past sector events for ENANTA PHARMACEUTICALS, INC.
01/21/21 | 10:30pm BIOCON LIMITED : Q3 2021 Earnings Call
01/21/21 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. : Extraordinary Shareholders Meeting
01/21/21 BIOCON LIMITED : Q3 2021 Earnings Release
01/20/21 | 01:00pm IOVANCE BIOTHERAPEUTICS, INC. : B. Riley Oncology Investor Conference
Annual publications
Annual results201620172018201920202021 (e)
Sales
M $
Released
Forecast
Spread
88,3
88,8
-0,58%
103
101
2,0%
207
208
-0,87%
205
210
-2,2%
122
125
-1,7%

99,2
Operating income
(EBITDA)
M $
Released
Forecast
Spread


26,8

90,8

59,2
46,0
29%
-18,4
-44,0
58%

-107
Operating profit
(EBIT)
M $
Released
Forecast
Spread
30,8
31,4
-1,7%
24,6
22,7
8,5%
88,3
85,1
3,7%
36,7
42,0
-12%
-41,6
-43,9
5,2%

-91,3
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
32,6
32,7
-0,51%
26,9
24,2
11%
93,1
90,2
3,2%
45,6
51,2
-11%
-35,0
-37,3
6,1%

-89,7
Net income
M $
Released
Forecast
Spread
21,7
21,4
1,1%
17,7
18,4
-3,8%
72,0
69,9
2,9%
46,4
49,6
-6,6%
-36,2
-25,4
-42%

-86,2
EPS
$
Released
Forecast
Spread
1,13
1,08
4,6%
0,91
0,92
-1,0%
3,48
3,38
2,9%
2,21
2,35
-6,0%
-1,81
-1,29
-40%

-4,14
Announcement Date11/21/201611/20/201711/26/201811/21/201911/23/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q42020 Q12020 Q22020 Q32020 Q42021 Q1 (e)
Sales
M $
Released
Forecast
Spread
51,3
55,9
-8,3%
52,6
58,7
-11%
27,6
29,2
-5,3%
18,7
25,5
-27%
23,6
25,8
-8,2%

27,2
Operating income
(EBITDA)
M $
Released
Forecast
Spread
11,8
19,0
-38%
13,8
12,3
12%
-11,0
-15,8
31%






Operating profit
(EBIT)
M $
Released
Forecast
Spread
6,43
11,7
-45%
12,9
12,4
4,0%
-11,9
-17,8
33%
-22,9
-22,7
-0,85%
-19,8
-22,0
10%

-18,4
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
8,71
14,4
-39%
14,9
14,2
5,5%
-9,93
-16,3
39%
-21,4
-22,0
2,7%
-18,6
-20,8
10%

-18,4
Net income
M $
Released
Forecast
Spread
9,19
12,3
-25%
13,4
11,8
14%
-6,01
-16,3
63%
-14,3
-20,8
32%
-29,3
-18,5
-58%

-17,2
EPS
$
Released
Forecast
Spread
0,44
0,56
-21%
0,65
0,56
15%
-0,30
-0,73
59%
-0,71
-0,97
26%
-1,46
-0,94
-55%

-0,83
Announcement Date11/21/201902/06/202005/06/202008/04/202011/23/2020

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise